SRC-3 is a pan-cancer oncogene that functions in a cell-autonomous manner within cancer cells, that is strongly associated with multiple malignancies (38–45) and has been particularly well studied in estrogen receptor positive breast cancer (BC) (38, 46–52). Here, NCOA3 is linked to breast cancer.